Navigation Links
Reportlinker Adds Neurostimulation Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
Date:8/31/2010

NEW YORK, Aug. 31 /PRNewswire/ Reportlinker.com announces that a new market research report is available in its catalogue:

Neurostimulation Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

http://www.reportlinker.com/p0285077/Neurostimulation-Devices---Global-Pipeline-Analysis--Opportunity-Assessment-and-Market-Forecasts-to-2016.html

Neurostimulation Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

Summary

GlobalData's new report, "Neurostimulation Devices – Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016" provides key data, information and analysis on the global neurostimulation devices market. The report provides market landscape, competitive landscape and market trends information the neurostimulation devices market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape, key pipeline products and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.

- Key segments covered include Deep Brain Stimulators, Spinal Cord Stimulators and Vagus Nerve Stimulators.

- Annualized market revenues data from 2002 to 2009, forecast forward for 7 years to 2016. Company shares data for 2009.

- Qualitative analysis of key market trends, market drivers, and restraints by each category within the neurostimulation devices market.

- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.

- Key players covered include Medtronic, St. Jude Medical, Boston Scientific Corporation and Cyberonics.

Reasons to buy

- Develop business strategies by understanding the trends and developments that are driving the neurostimulation devices market globally.

- Design and develop your product development, marketing and sales strategies.

- Exploit M&A opportunities by identifying market players with the most innovative pipeline.

- Develop market-entry and market expansion strategies.

- Identify key players best positioned to take advantage of the emerging market opportunities.

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.

- What's the next being thing in the neurostimulation devices market landscape? – Identify, understand and capitalize.

- Make more informed business decisions from the insightful and in-depth analysis of the global neurostimulation devices market and the factors shaping it.

1 Table of contents

1 Table of contents 3

1.1 List of Tables 6

1.2 List of Figures 7

2 Introduction and Overview 8

2.1 GlobalData Report Guidance 8

3 Disease Overview 9

3.1 Disease Overview: Parkinson's Disease 9

3.1.1 Introduction 9

3.1.2 Etiology 9

3.1.3 Signs and Symptoms 10

3.1.4 Pathophysiology 10

3.1.5 Treatment 11

3.1.6 Epidemiology 11

3.2 Disease Overview: Chronic Pain 11

3.2.1 Introduction 11

3.2.2 Etiology 12

3.2.3 Signs and Symptoms 12

3.2.4 Pathophysiology 12

3.2.5 Treatment 12

3.2.6 Epidemiology 13

3.3 Disease Overview: Epilepsy 13

3.3.1 Introduction 13

3.3.2 Etiology 14

3.3.3 Signs and Symptoms 14

3.3.4 Pathophysiology 14

3.3.5 Treatment 15

3.3.6 Epidemiology 15

4 Neurostimulation Device Based Treatment Overview 16

4.1 Neurostimulation Devices: Technology Overview 16

4.1.1 Introduction 16

4.1.2 Advantages and Disadvantages of Neurostimulation Therapy 17

4.1.3 Types of Neurostimulators 17

5 Global Neurostimulation Devices Market: Global Market Characterization 19

5.1 Global Neurostimulation Devices Market, Revenues($m), 2002 - 2009 19

5.2 Global Neurostimulation Devices Market, Revenues($m), 2009 - 2016 20

5.3 Neurostimulation Devices: Key Market Trends 21

5.4 Neurostimulation Devices: Market Dynamics 21

5.4.1 Market Drivers 21

5.4.2 Market Restraints 23

5.5 Neurostimulation Devices: Key Opportunities and Unmet Needs 23

5.5.1 Opportunities 23

5.5.2 Unmet Need 24

6 Global Neurostimulation Devices Market: Segment Wise Analysis 25

6.1 Deep Brain Stimulation Devices Market: Market Characterization 25

6.1.1 Deep Brain Stimulation Devices Market, Revenues ($m), 2002 - 2009 25

6.1.2 Deep Brain Stimulation Devices Market, Revenues ($m), 2009 - 2016 26

6.2 Spinal Cord Stimulation Devices Market: Market Characterization 27

6.2.1 Spinal Cord Stimulation Devices Market, Revenues ($m), 2002 - 2009 27

6.2.2 Spinal Cord Stimulation Devices Market, Revenues ($m), 2009 - 2016 28

6.3 Vagus Nerve Stimulation Devices Market: Market Characterization 29

6.3.1 Vagus Nerve Stimulation Devices Market, Revenues ($m), 2002 - 2009 29

6.3.2 Vagus Nerve Stimulation Devices Market, Revenues ($m), 2009 - 2016 30

7 Global Neurostimulation Devices Market: Country Wise Market Analysis and Forecasts 31

7.1 Global Neurostimulation Devices Market: Cross-Country Market Analysis and Forecasts 31

7.1.1 Cross-Country Analysis of Neurostimulation Devices market, 2009 31

7.2 Revenues and Forecasts, By Country 32

7.2.1 US Neurostimulation Devices Market, Revenues ($m), By Segment, 2002 – 2009 32

7.2.2 US Neurostimulation Devices Market, Revenues ($m), By Segment, 2009 – 2016 33

7.2.3 Canada Neurostimulation Devices Market, Revenues ($m), By Segment, 2002 – 2009 34

7.2.4 Canada Neurostimulation Devices Market, Revenues ($m), By Segment, 2009 – 2016 35

7.2.5 UK Neurostimulation Devices Market, Revenues ($m), By Segment, 2002 – 2009 36

7.2.6 UK Neurostimulation Devices Market, Revenues ($m), By Segment, 2009 – 2016 37

7.2.7 Germany Neurostimulation Devices Market, Revenues ($m), By Segment, 2002 – 2009 38

7.2.8 Germany Neurostimulation Devices Market, Revenues ($m), By Segment, 2009 – 2016 39

7.2.9 France Neurostimulation Devices Market, Revenues ($m), By Segment, 2002 – 2009 40

7.2.10 France Neurostimulation Devices Market, Revenues ($m), By Segment, 2009 – 2016 41

7.2.11 Italy Neurostimulation Devices Market, Revenues ($m), By Segment, 2002 – 2009 42

7.2.12 Italy Neurostimulation Devices Market, Revenues ($m), By Segment, 2009 – 2016 43

7.2.13 Spain Neurostimulation Devices Market, Revenues ($m), By Segment, 2002 – 2009 44

7.2.14 Spain Neurostimulation Devices Market, Revenues ($m), By Segment, 2009 – 2016 45

7.2.15 Japan Neurostimulation Devices Market, Revenues ($m), By Segment, 2002 – 2009 46

7.2.16 Japan Neurostimulation Devices Market, Revenues ($m), By Segment, 2009 – 2016 47

7.2.17 China Neurostimulation Devices Market, Revenues ($m), By Segment, 2002 – 2009 48

7.2.18 China Neurostimulation Devices Market, Revenues ($m), By Segment, 2009 – 2016 49

7.2.19 India Neurostimulation Devices Market, Revenues ($m), By Segment, 2002 – 2009 50

7.2.20 India Neurostimulation Devices Market, Revenues ($m), By Segment, 2009 – 2016 51

7.2.21 Australia Neurostimulation Devices Market, Revenues ($m), By Segment, 2002 - 2009 52

7.2.22 Australia Neurostimulation Devices Market, Revenues ($m), By Segment, 2009 – 2016 53

7.2.23 Brazil Neurostimulation Devices Market, Revenues ($m), By Segment, 2002 – 2009 54

7.2.24 Brazil Neurostimulation Devices Market, Revenues ($m), By Segment, 2009 – 2016 55

8 Global Neurostimulation Devices Market: Competitive Assessment 56

8.1 Global Neurostimulation Devices Market, Key Company Shares (%), 2009 56

8.2 Medtronic, Inc 57

8.2.1 Overview 57

8.2.2 Neurostimulation Devices Portfolio 57

8.3 St. Jude Medical, Inc 57

8.3.1 Overview 57

8.3.2 Neurostimulation Devices Portfolio 57

8.4 Boston Scientific Corporation 58

8.4.1 Overview 58

8.4.2 Neurostimulation Devices Portfolio 58

8.5 Cyberonics, Inc 58

8.5.1 Overview 58

8.5.2 Neurostimulation Devices Portfolio 58

9 Global Neurostimulation Devices Market: Key Marketed Products 59

9.1 Medtronic, Inc: Activa RC 59

9.1.1 Product Description 59

9.1.2 Features and Benefits 59

9.2 Medtronic, Inc: RestoreUltra 59

9.2.1 Product Description 59

9.2.2 Features and Benefits 59

9.3 St. Jude's Medical, Inc: Eon Mini 59

9.3.1 Product Description 59

9.3.2 Features and Benefits 59

9.4 Boston Scientific Corporation: Precision Plus 60

9.4.1 Product Description 60

9.4.2 Features and Benefits 60

9.5 Cyberonics, Inc: VNS Therapy 60

9.5.1 Product Description 60

9.5.2 Features and Benefits 60

10 Global Neurostimulation Devices Market: Strategic Pipeline Assessment 61

10.1 Neurostimulation Devices: List of Pipeline Products 61

10.2 Pipeline Products Assessment for Neurostimulation Devices by Segment, Global, 2010 64

10.3 Neurostimulation Devices: Profiles of Pipeline Products Under Clinical Development 65

10.3.1 Cyberonics, Inc: 3T MRI Safe Lead 65

10.3.2 Boston Scientific Corporation: Bion Microstimulator System for chronic headache 65

10.3.3 Brainsway, Inc: Deep TMS H System 65

10.3.4 Intelect Medical, Inc: Enspire DBS Therapy System for Stroke 65

10.3.5 Magstim Company Limited: Magstim eldith DC Stimulator plus 65

10.3.6 DynaMed Systems, LLC: Traxon 66

11 Global Neurostimulation Devices Market: M&A Landscape 67

11.1 Global Neurostimulation Devices Market: Deals Overview 67

11.2 Global Neurostimulation Devices Market: Key Acquisitions 68

11.2.1 St. Jude Medical Acquires Northstar Neuroscience 69

11.2.2 Greatbatch Acquires Quan Emerteq 69

11.2.3 Greatbatch Acquires Enpath Medical 70

12 Appendix 71

12.1 Definitions 71

12.2 Acronyms 71

12.3 Information Sources 73

12.4 Research Methodology 73

12.5 Secondary Research 74

12.6 Primary Research 75

12.7 Models 75

12.8 Forecasts 75

12.9 Expert Panels 75

12.10 GlobalData Consulting 76

12.11 Contact Us 76

12.12 Disclaimer 76

1.1 List of Tables

Table 1: Neurostimulation Devices Market, Global, Revenues ($m), 2002 - 2009 19

Table 2: Neurostimulation Devices Market, Global, Revenues ($m), 2009 - 2016 20

Table 3: Deep Brain Stimulation Devices Market, Global, Revenues ($m), 2002 - 2009 25

Table 4: Deep Brain Stimulation Devices Market, Global, Revenues ($m), 2009 - 2016 26

Table 5: Spinal Cord Stimulation Devices Market, Global, Revenues ($m), 2002 - 2009 27

Table 6: Spinal Cord Stimulation Devices Market, Global, Revenues ($m), 2009 - 2016 28

Table 7: Vagus Nerve Stimulation Devices Market, Global, Revenues ($m), 2002 - 2009 29

Table 8: Vagus Nerve Stimulation Devices Market, Global, Revenues ($m), 2009 - 2016 30

Table 9: Neurostimulation Devices Market, Global, Market Analysis by Countries, 2002 - 2016 31

Table 10: Neurostimulation Devices Market, US, Revenues ($m), By Segment, 2002 – 2009 32

Table 11: Neurostimulation Devices Market, US, Revenues ($m), By Segment, 2009 – 2016 33

Table 12: Neurostimulation Devices Market, Canada, Revenues ($m), By Segment, 2002 – 2009 34

Table 13: Neurostimulation Devices Market, Canada, Revenues ($m), By Segment, 2009 – 2016 35

Table 14: Neurostimulation Devices Market, UK, Revenues ($m), By Segment, 2002 – 2009 36

Table 15: Neurostimulation Devices Market, UK, Revenues ($m), By Segment, 2009 – 2016 37

Table 16: Neurostimulation Devices Market, Germany, Revenues ($m), By Segment, 2002 – 2009 38

Table 17: Neurostimulation Devices Market, Germany, Revenues ($m), By Segment, 2009 – 2016 39

Table 18: Neurostimulation Devices Market, France, Revenues ($m), By Segment, 2002 – 2009 40

Table 19: Neurostimulation Devices Market, France, Revenues ($m), By Segment, 2009 – 2016 41

Table 20: Neurostimulation Devices Market, Italy, Revenues ($m), By Segment, 2002 – 2009 42

Table 21: Neurostimulation Devices Market, Italy, Revenues ($m), By Segment, 2009 – 2016 43

Table 22: Neurostimulation Devices Market, Spain, Revenues ($m), By Segment, 2002 – 2009 44

Table 23: Neurostimulation Devices Market, Spain, Revenues ($m), By Segment, 2009 – 2016 45

Table 24: Neurostimulation Devices Market, Japan, Revenues ($m), By Segment, 2002 – 2009 46

Table 25: Neurostimulation Devices Market, Japan, Revenues ($m), By Segment, 2009 – 2016 47

Table 26: Neurostimulation Devices Market, China, Revenues ($m), By Segment, 2002 – 2009 48

Table 27: Neurostimulation Devices Market, China, Revenues ($m), By Segment, 2009 – 2016 49

Table 28: Neurostimulation Devices Market, India, Revenues ($m), By Segment, 2002 – 2009 50

Table 29: Neurostimulation Devices Market, India, Revenues ($m), By Segment, 2009 – 2016 51

Table 30: Neurostimulation Devices Market, Australia, Revenues ($m), By Segment, 2002 - 2009 52

Table 31: Neurostimulation Devices Market, Australia, Revenues ($m), By Segment, 2009 – 2016 53

Table 32: Neurostimulation Devices Market, Brazil, Revenues ($m), By Segment, 2002 – 2009 54

Table 33: Neurostimulation Devices Market, Brazil, Revenues ($m), By Segment, 2009 – 2016 55

Table 34: Neurostimulation Devices Market, Global, Key Company Shares ($m), 2009 56

Table 35: Medtronic, Inc., Key Marketed Products, Neurostimulation Devices Category 57

Table 36: St. Jude Medical, Inc. Key Marketed Products, Neurostimulation Devices Category 57

Table 37: Boston Scientific Corp., Key Marketed Products, Neurostimulation Devices Category 58

Table 38: Cyberonics, Inc , Key Marketed Products, Neurostimulation Devices Category 58

Table 39: Activa RC Deep Brain Neurostimulator, Features and Benefits 59

Table 40: RestoreUltra Spinal Cord Neurostimulator, Features and Benefits 59

Table 41: Eon Mini Spinal Cord Stimulator, Features and Benefits 59

Table 42: Precision Plus Spinal Cord Stimulator, Features and Benefits 60

Table 43: VNS Therapy Features and Benefits 60

Table 44: Neurostimulation Devices, Pipeline Products, 2010, Table 1 61

Table 45: Neurostimulation Devices, Pipeline Products, 2010, Table 2 62

Table 46: Neurostimulation Devices, Pipeline Products, 2010, Table 3 63

Table 47: Neurostimulation Devices Market, Global, Deals Overview, 2005 - 2009 67

Table 48: Neurostimulation Devices Market, Global, M&A Deal Value ($m), 2005 - 2009 68

Table 49: Neurostimulation Devices Industry, Global, List of M&A Deals, 2004 - 2010 69

1.2 List of Figures

Figure 1: Neurostimulation Therapy, FDA Year of Approval 17

Figure 2: Neurostimulation Devices Market, Global, Revenues ($m), 2002 - 2009 19

Figure 3: Neurostimulation Devices Market, Global, Revenues ($m), 2009 - 2016 20

Figure 4: Potential of Neurostimulation Devices for the Treatment of Various Indications, 2010 21

Figure 5: Deep Brain Stimulation Devices Market, Global, Revenues ($m), 2002 - 2009 25

Figure 6: Deep Brain Stimulation Devices Market, Global, Revenues ($m), 2009 - 2016 26

Figure 7: Spinal Cord Stimulation Devices Market, Global, Revenues ($m), 2002 - 2009 27

Figure 8: Spinal Cord Stimulation Devices Market, Global, Revenues ($m), 2009 - 2016 28

Figure 9: Vagus Nerve Stimulation Devices Market, Global, Revenues ($m), 2002 - 2009 29

Figure 10: Vagus Nerve Stimulation Devices Market, Global, Revenues ($m), 20016 30

Figure 11: Neurostimulation Devices Market, Global, Market Analysis by Countries, 2002 - 2016 31

Figure 12: Neurostimulation Devices Market, US, Revenues ($m), By Segment, 2002 – 2009 32

Figure 13: Neurostimulation Devices Market, US, Revenues ($m), By Segment, 2009 – 2016 33

Figure 14: Neurostimulation Devices Market, Canada, Revenues ($m), By Segment, 2002 – 2009 34

Figure 15: Neurostimulation Devices Market, Canada, Revenues ($m), By Segment, 2009 – 2016 35

Figure 16: Neurostimulation Devices Market, UK Revenues ($m), By Segment, 2002 – 2009 36

Figure 17: Neurostimulation Devices Market, UK, Revenues ($m), By Segment, 2009 – 2016 37

Figure 18: Neurostimulation Devices Market, Germany, Revenues ($m), By Segment, 2002 – 2009 38

Figure 19: Neurostimulation Devices Market, Germany, Revenues ($m), By Segment, 2009 – 2016 39

Figure 20: Neurostimulation Devices Market, France, Revenues ($m), By Segment, 2002 – 2009 40

Figure 21: Neurostimulation Devices Market, France, Revenues ($m), By Segment, 2009 – 2016 41

Figure 22 Neurostimulation Devices Market, Italy, Revenues ($m), By Segment, 2002 – 2009 42

Figure 23: Neurostimulation Devices Market, Italy, Revenues ($m), By Segment, 2009 – 2016 43

Figure 24: Neurostimulation Devices Market, Spain, Revenues ($m), By Segment, 2002 – 2009 44

Figure 25: Neurostimulation Devices Market, Spain, Revenues ($m), By Segment, 2009 – 2016 45

Figure 26: Neurostimulation Devices Market, Japan, Revenues ($m), By Segment, 2002 – 2009 46

Figure 27: Neurostimulation Devices Market, Japan, Revenues ($m), By Segment, 2009 – 2016 47

Figure 28: Neurostimulation Devices Market, China, Revenues ($m), By Segment, 2002 – 2009 48

Figure 29: Neurostimulation Devices Market, China, Revenues ($m), By Segment, 2009 – 2016 49

Figure 30: Neurostimulation Devices Market, India, Revenues ($m), By Segment, 2002 – 2009 50

Figure 31: Neurostimulation Devices Market, India, Revenues ($m), By Segment, 2009 – 2016 51

Figure 32: Neurostimulation Devices Market, Australia, Revenues ($m), By Segment, 2002 - 2009 52

Figure 33: Neurostimulation Devices Market, Australia. Revenues ($m), By Segment, 2009 – 2016 53

Figure 34: Neurostimulation Devices Market, Brazil, Revenues ($m), By Segment, 2002 - 2016 54

Figure 35: Neurostimulation Devices Market, Brazil, Revenues ($m), By Segment, 2009 – 2016 55

Figure 36: : Neurostimulation Devices Market, Global, Key Company Shares (%), 2009 56

Figure 37: Pipeline Product Assessment for Neurostimulation Devices by Segment, Global 64

Figure 38: Neurostimulation Devices Market, Global, Deals Overview, 2005 - 2009 67

Figure 39: Neurostimulation Devices Market, Global, M&A Deal Value ($m), 2005 - 2009 68

Figure 40: GlobalData Methodology 74

Companies mentioned

Medtronic, Inc

St. Jude Medical, Inc

Boston Scientific Corporation

Cyberonics, Inc

To order this report:

Medical Devices Industry: Neurostimulation Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

Medical Devices Business News

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg

Reportlinker

Email: nbo@reportlinker.com

US: (805)652-2626

Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved


Related medicine technology :

1. Reportlinker Adds The Market for Medical Devices in Brazil, Russia, India & China
2. Reportlinker Adds Pharmaceutical Contract Sales Organizations (CSO) - Emerging Markets to Drive Growth but Talent Acquisition in Specialty Secondary Care Remains a Challenge
3. Reportlinker Adds The Market for Pharmaceuticals in Brazil, Russia, India & China
4. Reportlinker Adds Erectile Dysfunction - Pipeline Assessment and Market Forecasts to 2017
5. Reportlinker Adds Hormone Replacement Therapy in Menopause - Pipeline Assessment and Market Forecasts to 2017
6. Reportlinker Adds Insulin Pumps - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
7. Reportlinker Adds Threats to Avastin - Targeting the VEGF Pathway
8. Reportlinker Adds The Outlook for Pharmaceuticals In The Middle East And North Africa To 2015
9. Reportlinker Adds Epigenetics: Current and future applications that are driving novel drug discovery
10. Reportlinker Adds Clinical Laboratory Testing Volume 1: Reagents and Instruments
11. Reportlinker Adds Portable and Transport Ventilator Market Shares, Strategies, and Forecasts, Worldwide, 2010 to 2016
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... , Net Sales of $1.90 billion represent an increase ... period, and an increase of 1.2% on an adjusted pro ... first quarter were $0.52 reported, a decrease of 47.5% from ... 29.9% over the prior year period , The Company ... Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) ...
(Date:4/28/2016)... April 28, 2016  ValGenesis, Inc., the ... Solutions (VLMS) today announced that a prominent ... sufferers of chronic kidney failure has selected ... their corporate validation process. The global medical ... solution to manage their validation processes electronically. ...
(Date:4/27/2016)... , Schweiz, April 27, 2016 /PRNewswire/ ... des Sachs CEO Forums in Zürich gab ... ihres führenden Wirkstoffkandidaten STR001 zur Erhaltung des ... eingesetzt wurde, bekannt. Für die umfassende Phase-II-Doppelblindstudie ... und Frankreich angeworben. STR001 wird während der ...
Breaking Medicine Technology:
(Date:4/29/2016)... ... 29, 2016 , ... Melanoma is the deadliest type of skin cancer. Although only about 1 ... skin cancer deaths. More than 10,000 people are expected to die of melanoma this year. ... is the one of the most commonly diagnosed cancers in young women. A recent breakthrough ...
(Date:4/29/2016)... ... April 29, 2016 , ... Reltok Nasal Products proudly announces that Boston ... and neck/ear, nose and throat specialty, has added the KOTLER NASAL AIRWAY™ to its ... is a newly patented safety device secured by nasal surgeons onto the floor ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... Dairy Products, Inc. in an upcoming episode, airing third quarter 2016 via Discovery ... churning cream into butter, Grassland Dairy Products, located in Greenwood, Wisconsin applies product ...
(Date:4/29/2016)... ... April 29, 2016 , ... The infertility specialists at HRC Fertility/Orange County ... Dr. Daniel A. Potter -- are proud of the recent release of their 2014 ... April, SART published the latest verified data for 375 U.S. member clinics. ...
(Date:4/29/2016)... ... 29, 2016 , ... International Dehydrated Foods, Inc. (IDF™) will attend and sponsor ... the Doubletree by Hilton Hotel in Oak Brook, Illinois. The two-day event is the ... protein ingredients. , At the seminar, IDF™ will offer samples of its Savory ...
Breaking Medicine News(10 mins):